Johnson & Johnson
- Consumer Products
- Latest 103.13
- Currency US$
- Change 0.50
- Percent Change 0.487 %
- Volume 5,973,142
- Fri Oct 24, 2014 04:00 PM EDT NYSE data delayed 15 minutes.
12 months ended Mar 31, 2014.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Oct 14||$1.42||Jan 20||$1.25|
|Dividends||Aug 22||$0.70||Nov 21||$0.70|
12 months ended Oct 24, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Head OfficeONE JOHNSON & JOHNSON PLZ